The primary objective is to assess in terms of frequency the adverse outcomes (premature birth, maternal-fetal haemorrhage, maternal fetal-neonatal death) of pregnancies of women attending the obstetric-gynaecological emergency department for genital bleeding beyond the 18th week of pregnancy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Rate of hospitalization for genital blood loss
Timeframe: After the 18th week of pregnancy
Percentage of preterm births
Timeframe: After delivery, up to 24 weeks
Percentage of spontaneous deliveries, operative vaginal, cesarean sections (elective, urgent, emergent)
Timeframe: After delivery, up to 24 weeks
Frequency of antihemorrhagic therapy and maternal transfusions
Timeframe: Intra-partum and post-partum, up to 24 weeks
Frequency of live births, average APGAR, average pH of umbilical artery or vein, average neonatal weight
Timeframe: After delivery, up to 24 weeks
Average length of hospitalization in hours
Timeframe: During Hospitalization, up to 24 weeks